ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 52 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2015. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $112,000 | -25.3% | 11,884 | -42.3% | 0.01% | -8.3% |
| Q2 2018 | $150,000 | -80.1% | 20,591 | -86.4% | 0.01% | -72.1% |
| Q1 2018 | $755,000 | -42.8% | 151,078 | -42.2% | 0.04% | -55.2% |
| Q4 2017 | $1,320,000 | -14.8% | 261,326 | +4.5% | 0.10% | -5.9% |
| Q3 2017 | $1,550,000 | +14.6% | 250,015 | -33.5% | 0.10% | +13.3% |
| Q2 2017 | $1,353,000 | -2.7% | 375,854 | -12.2% | 0.09% | -21.7% |
| Q1 2017 | $1,391,000 | +27.8% | 427,967 | -3.6% | 0.12% | +11.7% |
| Q4 2016 | $1,088,000 | -99.0% | 443,887 | +311.0% | 0.10% | -65.7% |
| Q3 2016 | $107,990,000 | +48764.3% | 107,990 | +69.9% | 0.30% | +934.5% |
| Q2 2016 | $221,000 | +79.7% | 63,550 | +113.6% | 0.03% | +70.6% |
| Q1 2016 | $123,000 | -45.6% | 29,754 | -19.9% | 0.02% | -54.1% |
| Q3 2015 | $226,000 | – | 37,135 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |